☰

Aaron M. D'Antona, Ph.D. - Publications

Affiliations: 
2006 University of Connecticut, Storrs, CT, United States 
Area:
Molecular Biology
Tree Info Similar researchers PubMed Report error

8/25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zhong X, Jagarlapudi S, Weng Y, Ly M, Rouse JC, McClure K, Ishino T, Zhang Y, Sousa E, Cohen J, Tzvetkova B, Cote K, Scarcelli JJ, Johnson K, Palandra J, et al. Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease. The Journal of Biological Chemistry. PMID 32005658 DOI: 10.1074/Jbc.Ra119.012144  0.38
2011 Xie G, D'Antona AM, Edwards PC, Fransen M, Standfuss J, Schertler GF, Oprian DD. Preparation of an activated rhodopsin/transducin complex using a constitutively active mutant of rhodopsin. Biochemistry. 50: 10399-407. PMID 21995315 DOI: 10.1021/Bi201126R  0.341
2011 Standfuss J, Edwards PC, D'Antona A, Fransen M, Xie G, Oprian DD, Schertler GF. The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature. 471: 656-60. PMID 21389983 DOI: 10.1038/Nature09795  0.477
2009 D'Antona A, Xie G, Fransen M, Edwards PC, Schertler GF, Oprian DD. Purification and Characterization of an Activated Rhodopsin/Transducin Complex Biophysical Journal. 96: 594a. DOI: 10.1016/J.Bpj.2008.12.3172  0.384
2006 D'Antona AM, Ahn KH, Wang L, Mierke DF, Lucas-Lenard J, Kendall DA. A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation. Brain Research. 1108: 1-11. PMID 16879811 DOI: 10.1016/J.Brainres.2006.05.042  0.542
2006 D'Antona AM, Ahn KH, Kendall DA. Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization. Biochemistry. 45: 5606-17. PMID 16634642 DOI: 10.1021/Bi060067K  0.646
2004 Leggett JD, Aspley S, Beckett SR, D'Antona AM, Kendall DA, Kendall DA. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. British Journal of Pharmacology. 141: 253-62. PMID 14707029 DOI: 10.1038/Sj.Bjp.0705607  0.543
2003 Andersson H, D'Antona AM, Kendall DA, Von Heijne G, Chin CN. Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail. Molecular Pharmacology. 64: 570-7. PMID 12920192 DOI: 10.1124/Mol.64.3.570  0.606
Low-probability matches (unlikely to be authored by this person)
2014 D'Antona AM, Xie G, Sligar SG, Oprian DD. Assembly of an activated rhodopsin-transducin complex in nanoscale lipid bilayers. Biochemistry. 53: 127-34. PMID 24328127 DOI: 10.1021/Bi4012995  0.203
2018 Zhong X, Ma W, Meade CL, Tam AS, Llewellyn E, Cornell R, Cote K, Scarcelli JJ, Marshall JK, Tzvetkova B, Figueroa B, DiNino D, Sievers A, Lee C, Guo J, et al. A Transient CHO Expression Platform for Robust Antibody Production and Its Enhanced N-Glycan Sialylation on Therapeutic Glycoproteins. Biotechnology Progress. PMID 30299005 DOI: 10.1002/btpr.2724  0.178
2013 Zhong X, Kieras E, Sousa E, D'Antona A, Baber JC, He T, Desharnais J, Wood L, Luxenberg D, Stahl M, Kriz R, Lin L, Somers W, Fitz LJ, Wright JF. Pyroglutamate and O-linked glycan determine functional production of anti-IL17A and anti-IL22 peptide-antibody bispecific genetic fusions. The Journal of Biological Chemistry. 288: 1409-19. PMID 23184956 DOI: 10.1074/jbc.M112.417717  0.162
2016 Root AR, Cao W, Li B, LaPan P, Meade C, Sanford J, Jin M, O'Sullivan C, Cummins E, Lambert M, Sheehan AD, Ma W, Gatto S, Kerns K, Lam K, et al. Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer. Antibodies (Basel, Switzerland). 5. PMID 31557987 DOI: 10.3390/antib5010006  0.159
2024 D'Antona AM, Lee JM, Zhang M, Friedman C, He T, Mosyak L, Bennett E, Lin L, Silverman M, Cometa F, Meade C, Hageman T, Sousa E, Cohen J, Marquette K, et al. Tyrosine Sulfation at Antibody Light Chain CDR-1 Increases Binding Affinity and Neutralization Potency to Interleukine-4. International Journal of Molecular Sciences. 25. PMID 38339208 DOI: 10.3390/ijms25031931  0.159
2023 West C, Federspiel J, Rogers K, Khatri A, Rao-Dayton S, Fernandez Ocana M, Lim S, D'Antona AM, Casinghino S, Somanathan S. Complement activation by AAV-neutralizing antibody complexes. Human Gene Therapy. PMID 37082966 DOI: 10.1089/hum.2023.018  0.158
2022 Zhong X, D'Antona AM. A potential antibody repertoire diversification mechanism through tyrosine sulfation for biotherapeutics engineering and production. Frontiers in Immunology. 13: 1072702. PMID 36569848 DOI: 10.3389/fimmu.2022.1072702  0.145
2017 Zhong X, He T, Prashad AS, Wang W, Cohen J, Ferguson D, Tam AS, Sousa E, Lin L, Tchistiakova L, Gatto S, D'Antona A, Luan YT, Ma W, Zollner R, et al. Mechanistic understanding of the cysteine capping modifications of antibodies enables selective chemical engineering in live mammalian cells. Journal of Biotechnology. PMID 28300660 DOI: 10.1016/j.jbiotec.2017.03.006  0.143
2022 Zhong X, Schwab A, Ma W, Meade CL, Zhou J, D'Antona AM, Somers W, Lin L. Large-Scale Transient Production in ExpiCHO-S™ with Enhanced N-Galactosylation-Sialylation and PEI-Based Transfection. Methods in Molecular Biology (Clifton, N.J.). 2313: 143-150. PMID 34478135 DOI: 10.1007/978-1-0716-1450-1_7  0.131
2021 Root AR, Guntas G, Katragadda M, Apgar JR, Narula J, Chang CS, Hanscom S, McKenna M, Wade J, Meade C, Ma W, Guo Y, Liu Y, Duan W, Hendershot C, et al. Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors. Mabs. 13: 1850395. PMID 33459147 DOI: 10.1080/19420862.2020.1850395  0.13
2022 Zhong X, D'Antona AM, Scarcelli JJ, Rouse JC. New Opportunities in Glycan Engineering for Therapeutic Proteins. Antibodies (Basel, Switzerland). 11. PMID 35076453 DOI: 10.3390/antib11010005  0.116
2020 Apgar JR, Tam ASP, Sorm R, Moesta S, King AC, Yang H, Kelleher K, Murphy D, D'Antona AM, Yan G, Zhong X, Rodriguez L, Ma W, Ferguson DE, Carven GJ, et al. Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design. Plos One. 15: e0232713. PMID 32379792 DOI: 10.1371/Journal.Pone.0232713  0.116
2021 Tevelev B, Patel H, Shields K, Wei W, Cooley C, Zhang S, Bitzas G, Duan W, Khetemenee L, Jackobek R, D'Antona A, Sievers A, King A, Tam A, Zhang Y, et al. Genetic Rearrangement During Site Specific Integration Event Facilitates Cell Line Development of a Bispecific Molecule. Biotechnology Progress. e3158. PMID 33891804 DOI: 10.1002/btpr.3158  0.095
2023 Zhou J, Yan GG, Cluckey D, Meade C, Ruth M, Sorm R, Tam AS, Lim S, Petridis C, Lin L, D'Antona AM, Zhong X. Exploring Parametric and Mechanistic Differences between Expi293F and ExpiCHO-S Cells for Transient Antibody Production Optimization. Antibodies (Basel, Switzerland). 12. PMID 37606437 DOI: 10.3390/antib12030053  0.094
2020 Jackobek R, Herrick-Wagman S, Zhu L, Francis C, Solbrand A, Eriksson C, Berg M, Go D, D'Antona AM. Automated pH and conductivity conditioning using feedback control to support a two-step continuous purification process. Journal of Chromatography. A. 1630: 461537. PMID 32961387 DOI: 10.1016/j.chroma.2020.461537  0.071
2018 Ferguson DE, Mahan ER, Ma W, Bitzas G, Zhong X, Zollner R, D'Antona AM. Parallel loading and complete automation of a 3-step mAb purification process for multiple samples using a customized preparative chromatography instrument with networked pumps. Journal of Chromatography. A. PMID 29472072 DOI: 10.1016/j.chroma.2018.02.018  0.057
2021 Zhong X, D'Antona AM. Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics. Antibodies (Basel, Switzerland). 10. PMID 33808165 DOI: 10.3390/antib10020013  0.034
Hide low-probability matches.